These results suggest that the suppressive effects of roxatidine on NF-κB-regulated gene transcription are responsible for its anti-inflammatory effect via the regulation of the NF-κB and caspase-1 activation in this animal model of anaphylactic shock. This evidence concerns the gene CASP1 and anaphylaxis.